Second generation of temporary implantable nitinol device (iTind) in men with lower urinary tract symptoms (LUTS): Who profit most from treatment? 2 year results of the MT-02-study

Second generation of temporary implantable nitinol device (iTind) in men with lower urinary tract symptoms (LUTS): Who profit most from treatment? 2 year results of the MT-02-study

Bibliographic Details
Main Authors: G. Kadner, M. Valerio, I. Giannakis, M. Arya, N. Lumen, B.S. Ho, S. Alonso, C. Schulman, N. Barber, D. Amparore, F. Porpigila
Format: Article
Language:English
Published: Elsevier 2020-07-01
Series:European Urology Open Science
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168320328159

Internet

http://www.sciencedirect.com/science/article/pii/S2666168320328159

Similar Items